180 related articles for article (PubMed ID: 34446472)
1. Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
Oh H; Wild RA; Manson JE; Bea JW; Shadyab AH; Pfeiffer RM; Saquib N; Underland L; Anderson GL; Xu X; Trabert B
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2018-2029. PubMed ID: 34446472
[TBL] [Abstract][Full Text] [Related]
2. Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
Oh H; Saquib N; Ochs-Balcom HM; Pfeiffer RM; Richey PA; Shadyab AH; Wild RA; Underland L; Anderson GL; Xu X; Trabert B
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):97-107. PubMed ID: 34663616
[TBL] [Abstract][Full Text] [Related]
3. Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.
Oh H; Coburn SB; Matthews CE; Falk RT; LeBlanc ES; Wactawski-Wende J; Sampson J; Pfeiffer RM; Brinton LA; Wentzensen N; Anderson GL; Manson JE; Chen C; Zaslavsky O; Xu X; Trabert B
Breast Cancer Res; 2017 Mar; 19(1):28. PubMed ID: 28284224
[TBL] [Abstract][Full Text] [Related]
4. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
6. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study.
Trabert B; Michels KA; Anderson GL; Brinton LA; Falk RT; Geczik AM; Harris HR; Pan K; Pfeiffer RM; Qi L; Rohan T; Wentzensen N; Xu X
Int J Cancer; 2019 Oct; 145(8):2051-2060. PubMed ID: 30684389
[TBL] [Abstract][Full Text] [Related]
7. Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.
Geczik AM; Falk RT; Xu X; Ansong D; Yarney J; Wiafe-Addai B; Edusei L; Dedey F; Vanderpuye V; Titiloye N; Adjei E; Aitpillah F; Osei-Bonsu E; Oppong J; Biritwum R; Nyarko K; Wiafe S; Awuah B; Clegg-Lamptey JN; Ahearn TU; Figueroa J; Garcia-Closas M; Brinton LA; Trabert B
Breast Cancer Res; 2022 Jan; 24(1):9. PubMed ID: 35081987
[TBL] [Abstract][Full Text] [Related]
8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
9. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
[TBL] [Abstract][Full Text] [Related]
10. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
11. Is there a correlation between androgens and sexual desire in women?
Wåhlin-Jacobsen S; Pedersen AT; Kristensen E; Laessøe NC; Lundqvist M; Cohen AS; Hougaard DM; Giraldi A
J Sex Med; 2015 Feb; 12(2):358-73. PubMed ID: 25475395
[TBL] [Abstract][Full Text] [Related]
12. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women.
Stanczyk FZ; Chaikittisilpa S; Sriprasert I; Rafatnia A; Nadadur M; Mishell DR
Climacteric; 2019 Apr; 22(2):169-174. PubMed ID: 30612472
[TBL] [Abstract][Full Text] [Related]
13. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.
Labrie F; Bélanger A; Bélanger P; Bérubé R; Martel C; Cusan L; Gomez J; Candas B; Castiel I; Chaussade V; Deloche C; Leclaire J
J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):182-8. PubMed ID: 16621522
[TBL] [Abstract][Full Text] [Related]
14. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.
Danforth KN; Eliassen AH; Tworoger SS; Missmer SA; Barbieri RL; Rosner BA; Colditz GA; Hankinson SE
Int J Cancer; 2010 Jan; 126(1):199-207. PubMed ID: 19569181
[TBL] [Abstract][Full Text] [Related]
15. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
[TBL] [Abstract][Full Text] [Related]
18. Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study.
Heo M; Kabat GC; Strickler HD; Lin J; Hou L; Stefanick ML; Anderson GL; Rohan TE
J Womens Health (Larchmt); 2015 Mar; 24(3):218-27. PubMed ID: 25587642
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
Labrie F; Cusan L; Gomez JL; Martel C; Bérubé R; Bélanger P; Chaussade V; Deloche C; Leclaire J
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):1-9. PubMed ID: 18359622
[TBL] [Abstract][Full Text] [Related]
20. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
